The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: Rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery

American Heart Journal

Volumn 147, Issue 4, 2004, Pages 677-683

  Juul, Anne Benedicte ^a   Wetterslev, Jørn ^a   Kofoed Enevoldsen, Allan ^b   Callesen, Torben ^c   Jensen, Gorm ^d   Gluud, Christian ^a  

^a Mental Health Services CPH   (Denmark)

^b Esbjerg Varde Hospital   (Denmark)

^c Rigshospitalet   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL;

ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; MALE; MEDICAL EXAMINATION; MULTICENTER STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REDUCTION; SURGICAL TECHNIQUE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; METOPROLOL; MIDDLE AGED; MULTICENTER STUDIES; MYOCARDIAL ISCHEMIA; OUTCOME ASSESSMENT (HEALTH CARE); PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SURGICAL PROCEDURES, OPERATIVE;

EID: 3142617370     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2003.10.030     Document Type: Article

References (42)

1. Mangano D.T. Perioperative cardiac morbidity. Anesthesiology. 72:1990;153-184
2. Mangano D.T., Browner W.S., Hollenberg M., et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med. 323:1990;1781-1788
3. Browner W.S., Li J., Mangano D.T. In-hospital and long-term mortality in male veterans following noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA. 268:1992;228-232
4. Mangano D.T., Browner W.S., Hollenberg M., et al. Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA. 268:1992;233-239
5. Wallace A., Layug B., Tateo I., et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology. 88:1998;7-17
6. Pasternack P.F., Grossi E.A., Baumann F.G., et al. Silent myocardial ischemia monitoring predicts late as well as perioperative cardiac events in patients undergoing vascular surgery. J Vasc Surg. 16:1992;171-179
7. Mangano D.T., Wong M.G., London M.J., et al. Perioperative myocardial ischemia in patients undergoing noncardiac surgery - II Incidence and severity during the 1st week after surgery. The Study of Perioperative Ischemia (SPI) Research Group. J Am Coll Cardiol. 17:1991;851-857
8. Raby K.E., Barry J., Creager M.A., et al. Detection and significance of intraoperative and postoperative myocardial ischemia in peripheral vascular surgery. JAMA. 268:1992;222-227
9. Badner N.H., Knill R.L., Brown J.E., et al. Myocardial infarction after noncardiac surgery. Anesthesiology. 88:1998;572-578
10. Goldman L., Caldera D.L., Nussbaum S.R., et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 297:1977;845-850
11. Eagle K.A., Coley C.M., Newell J.B., et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med. 110:1989;859-866
12. von Knorring J. Postoperative myocardial infarction A prospective study in a risk group of surgical patients. Surgery. 90:1981;55-60
13. Godet G., Coriat P., Baron J.F., et al. Prevention of intraoperative myocardial ischemia during noncardiac surgery with intravenous diltiazem A randomized trial versus placebo. Anesthesiology. 66:1987;241-245
14. Oliver M.F., Goldman L., Julian D.G., et al. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease The European Mivazerol Trial (EMIT). Anesthesiology. 91:1999;951-961
15. Coriat P. Intravenous nitroglycerin dosage to prevent intraoperative myocardial ischemia during noncardiac surgery. Anesthesiology. 64:1986;409-410
16. Thomson I.R., Mutch W.A., Culligan J.D. Failure of intravenous nitroglycerin to prevent intraoperative myocardial ischemia during fentanyl-pancuronium anesthesia. Anesthesiology. 61:1984;385-393
17. Mangano D.T., Layug E.L., Wallace A., et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med. 335:1996;1713-1720
18. Poldermans D., Boersma E., Bax J.J., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med. 341:1999;1789-1794
19. Urban M.K., Markowitz S.M., Gordon M.A., et al. Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg. 90:2000;1257-1261
20. Raby K.E., Brull S.J., Timimi F., et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg. 88:1999;477-482
21. Ferguson T.B. Jr, Coombs L.P., Peterson E.D., et al. Preoperative β-blocker use and mortality and morbidity following CABG surgery in North America. JAMA. 287:2002;2221-2227
22. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Intern Med 1997;127:309-12
23. Eagle K.A., Berger P.B., Calkins H., et al. ACC/AHA Guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg. 94:2002;1052-1064
24. Kannel W.B., McGee D.L. Diabetes and glucose tolerance as risk factors for cardiovascular disease The Framingham study. Diabetes Care. 2:1979;120-126
25. Jacoby R.M., Nesto R.W. Acute myocardial infarction in the diabetic patient Pathophysiology, clinical course and prognosis. J Am Coll Cardiol. 20:1992;736-744
26. Redberg R.F., Greenland P., Fuster V., et al. Prevention Conference VI Diabetes and Cardiovascular Disease: Writing Group III: risk assessment in persons with diabetes. Circulation. 105:2002;e144-152
27. ICH harmonised tripartite guideline for good clinical practice. 3rd ed. Brookwood Medical Publications Ltd; 2002
28. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2000;284:3043-5
29. Lofdahl C.G., Dahlof C., Westergren G., et al. Controlled-release metoprolol compared with atenolol in asthmatic patients Interaction with terbutaline. Eur J Clin Pharmacol. 33:(Suppl):1988;S25-32
30. Sheifer S.E., Manolio T.A., Gersh B.J. Unrecognized myocardial infarction. Ann Intern Med. 135:2001;801-811
31. Ostor E., Schnohr P., Jensen G., et al. Electrocardiographic findings and their association with mortality in the Copenhagen City Heart Study. Eur Heart J. 2:1981;317-328
32. Juul AB, Wetterslev J, Kofoed-Enevoldsen A. Reducing postoperative mortality and cardiovascular morbidity after noncardiac surgery [abstract]. Presented at the Angelo-Danish-Dutch-diabetes-Group meeting, 1998, UK
33. Lerman J. Study design in clinical research Sample size estimation and power analysis. Can J Anaesth. 43:1996;184-191
34. Shammash J.B., Trost J.C., Gold J.M., et al. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J. 141:2001;148-153
35. Day S.J., Altman D.G. Statistics notes Blinding in clinical trials and other studies. BMJ. 321:2000;504
36. Altman D.G., Schulz K.F., Moher D., et al. The revised CONSORT statement for reporting randomized trials Explanation and elaboration. Ann Intern Med. 134:2001;663-694
37. Cruickshank J.M. Beta-blockers and diabetes The bad guys come good. Cardiovasc Drugs Ther. 16:2002;457-470
38. Gross M.L., El Shakmak A., Szabo A., et al. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Diabetologia. 46:2003;856-868
39. Nickelsen T.N. Data validity and coverage in the Danish National Health Registry A literature review [in Danish]. Ugeskr Laeger. 164:2001;33-37
40. Als-Nielsen B, Chen W, Gluud C, et al. Association of funding and conclusions in randomized drug trials. JAMA 2003;290:921-8
41. Kjaergard L.L., Als-Nielsen B. Association between competing interests and authors' conclusions Epidemiological study of randomised clinical trials published in the BMJ. BMJ. 325:2002;249
42. Bekelman J.E., Li Y., Gross C.P. Scope and impact of financial conflicts of interest in biomedical research A systematic review. JAMA. 289:2003;454-465